Research & Development

Sensulin has developed a proprietary drug delivery platform, called Agglomerated Vesicle Technology (AVT). The technology is covered by one issued U.S. patent and one US/PCT patent application. This platform is based upon a series of liposomes that are linked by a stimulus-responsive molecule, which can be used to encapsulate a variety of drugs, that are triggered by a variety of stimuli.

Please review Dr. Annapragada’s peer-reviewed publications, for more information on the system. If you are interested in testing our AVT delivery system, contact Mike Moradi by filling out the contact us form or call.